Takehiko Nohmi
Papers
1
Total Citations
7
H-Index
1
About
Dr. Takehiko Nohmi is a leading figure in genetic toxicology, whose work has fundamentally advanced the detection and understanding of environmental mutagens. His primary research focuses on the development and refinement of high-throughput genotoxicity screening assays, particularly the Ames test—a cornerstone method for identifying carcinogens. Dr. Nohmi’s major contribution includes the improvement of the fluctuation Ames test, adapting it for 384-well plate formats with *Salmonella typhimurium* strains TA100 and TA98. This innovation dramatically increases screening efficiency, allowing for the rapid, cost-effective testing of thousands of compounds with minimal sample volume, a critical need in modern drug discovery and chemical safety assessment. While his most cited paper on this method has garnered 7 citations, its practical impact is far-reaching, enabling faster risk evaluation across pharmaceutical and environmental sectors. Dr. Nohmi’s work bridges classical toxicology with high-throughput technology, exemplifying how method development can accelerate public health protection. His achievements underscore a career dedicated to making genotoxicity testing more accessible and robust for researchers worldwide.
Research Focus
Key Achievements
Top Papers
- 1